Attorneys General Support Efforts to Stop Robocallers from Misusing Legitimate Phone Numbers

November 15, 2021

The National Association of Attorneys General (NAAG) today wrote the Federal Communications Commission (FCC) in support of its efforts to reduce illegal robocallers’ access to legitimate phone numbers to make unending robocalls that scam people out of their hard-earned money. The comment letter to the FCC was signed by all 50 state attorneys general and…

Read More →

NAAG Supports Senate Hearings on Social Media and Mental Health

October 5, 2021

As enforcers of our jurisdictions’ consumer protection laws, we find it deeply troubling that Facebook and other social media platforms seek to increase user engagement by conscripting our nation’s youth despite known harms to children and adolescents.

Read More →

Attorneys General Urge FCC to Accelerate Deadline for STIR/SHAKEN Adoption

August 9, 2021

The National Association of Attorneys General (NAAG) today urged the Federal Communications Commission (FCC) to fight back against the scourge of illegal robocalls by moving up the deadline for smaller telephone companies to implement caller ID technology. Under the TRACED Act, which became law in 2019, phone companies are required to implement STIR/SHAKEN technology on…

Read More →

Texas et al. v. Google (In re Google Digital Advertising Antitrust Litigation), No. 1:21-cv-06841 (S.D.N.Y.)

July 12, 2021

The plaintiff states originally filed their case in the Eastern District of Texas (No. 4:20-cv-00957 (E.D. Tex. Dec. 16, 2020) alleging that Google monopolized or attempted to monopolize products and services used by advertisers and publishers in online-display advertising on third-party sites. The complaint also alleged that Google engaged in false, misleading and deceptive acts…

Read More →

Utah et al. v. Google LLC, No. 3:21-cv-05227 (N.D. Cal. July 7, 2021)

July 8, 2021

Thirty-seven states filed a lawsuit against Google for monopolizing the smartphone application market in violation of state and federal antitrust laws. According to the complaint, Google operates a web of exclusionary agreements with phone manufacturers and carriers to exert control over app distribution on Android phones through its Google Play Store. By leveraging those anticompetitive…

Read More →

NAAG Endorses State Antitrust Enforcement Venue Act of 2021

June 18, 2021

State attorneys general around the country are actively pursuing significant antitrust enforcement actions on behalf of consumers in their respective states.

Read More →

NAAG Asks Congress to Support State Antitrust Efforts

May 10, 2021

As Congress once again considers antitrust reform measures that will have significant impacts on our citizens and business communities for years to come, we encourage you to enhance the antitrust enforcement capabilities of the states, in addition to federal agencies. We thank you for your leadership on this important matter.

Read More →

NAAG Urges Facebook to Abandon Plans to Develop Instagram Kids

May 10, 2021

It appears that Facebook is not responding to a need, but instead creating one, as this platform appeals primarily to children who otherwise do not or would not have an Instagram account. In short, an Instagram platform for young children is harmful for myriad reasons. The attorneys general urge Facebook to abandon its plans to launch this new platform.

Read More →

United States and Plaintiff States v. Google, No. 1:20-cv-03010 (D.D.C. Oct. 20, 2020)

January 27, 2021

Eleven states and the U.S. Department of Justice filed a lawsuit to prevent Google from unlawfully maintaining monopolies through anticompetitive and exclusionary practices in the search and search advertising markets. According to the complaint, Google accounted for almost 90 percent of all search queries in the United States. Google has entered into a series of…

Read More →

Alabama et al. v. Endo International, No. 3:19-cv-04157 (N.D. Cal. July 19, 2019)

January 25, 2021

Eighteen states reached a settlement with Endo Pharmaceuticals Inc. under which Endo paid $2.3 million to settle allegations it entered into a reverse-payment agreement to obstruct generic competition to Lidoderm, a pain relief patch frequently used to treat shingles. According to the complaint, Endo had an agreement with Watson Laboratories Inc. ensuring Endo would not face…

Read More →